MediWound (MDWD) analyst forecast and price target
Analyst forecast
Consensus of 6 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Oppenheimer | Maintained | Outperform | $30.00 from $32.00 | Aug 14, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $36.00 | May 28, 2026 |
| Oppenheimer | Maintained | Outperform | $32.00 from $33.00 | May 28, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $36.00 from $31.00 | Nov 21, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $31.00 from $25.00 | May 22, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $25.00 | Mar 20, 2025 |
| Craig-Hallum | Initiated Coverage | Buy | $39.00 | Feb 28, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $25.00 | Jan 10, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $25.00 from $28.00 | Nov 27, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $28.00 | Oct 11, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $28.00 | Aug 15, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $28.00 | Jul 16, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $28.00 | May 30, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $28.00 | Mar 22, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $28.00 from $26.00 | Jan 16, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $26.00 | Nov 22, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $26.00 from $23.00 | Sep 21, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $23.00 | Aug 17, 2023 |
| Oppenheimer | Maintained | Outperform | $36.00 from $63.00 | Aug 17, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $23.00 | May 31, 2023 |
Frequently asked questions
Is MDWD a buy, sell, or hold?
Analysts covering MediWound currently average a Buy rating: 6 buy, 0 hold and 0 sell, from 6 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on MDWD?
On Aug 14, 2026, Oppenheimer maintained MediWound at Outperform with a price target of $30.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.
